Sign in Subscribe
Pharmaceutical industry

South Korea Anticipates Arrival of Pfizer Vaccines in Late February to Early March

Strategic Insights

— 1 min read

South Korea is on track to receive new coronavirus vaccines from American pharmaceutical company Pfizer between late February and early March, with initial inoculations using AstraZeneca vaccines produced in South Korea to begin in late February. The government plans to begin COVID-19 vaccinations later this month, with front-line medical workers receiving the first shots using the aforementioned AstraZeneca vaccines manufactured by SK Bioscience Co. in South Korea. The estimated time of arrival of Pfizer vaccines has been somewhat delayed, as previously mentioned by Prime Minister Chung Sye-kyun, who initially stated that the shipments from Pfizer would arrive as early as mid-February. The government is working to announce the results of their deliberations regarding vaccine efficacy and emergency use approval of AstraZeneca vaccines swiftly and transparently.

Key Takeaways:

  • The South Korean government expects to receive new coronavirus vaccines from Pfizer between late February and early March.
  • Initial inoculations using AstraZeneca vaccines produced in South Korea will begin in late February.
  • Front-line medical workers will receive the first shots using the AstraZeneca vaccines manufactured by SK Bioscience Co. in South Korea.
  • The estimated time of arrival of Pfizer vaccines has been delayed, as previously mentioned by Prime Minister Chung Sye-kyun.
  • The government plans to announce the results of their deliberations regarding vaccine efficacy and emergency use approval of AstraZeneca vaccines swiftly and transparently.
  • The Ministry of Food and Drug Safety approved the special import of 117,000 doses of Pfizer's vaccine for this month through the COVAX Facility.
  • The government is currently reviewing the results of expert panel deliberations regarding the use of AstraZeneca vaccines in people aged 65 or older.

Statistics:

  • 117,000: The number of doses of Pfizer's vaccine approved for import by the Ministry of Food and Drug Safety.
  • Late February to early March: The expected time frame for the arrival of Pfizer vaccines in South Korea.
  • 65 or older: The age group for which the expert panel has cautioned against inoculating with AstraZeneca vaccines, citing insufficient data.

Sources:

  • [Yonhap News Agency, 9 February 2021]

Read more